Literature DB >> 15099562

Immunity to latent viral infection: many skirmishes but few fatalities.

Kamal M Khanna1, Andrew J Lepisto, Robert L Hendricks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15099562     DOI： 10.1016/j.it.2004.02.010

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


× No keyword cloud information.
  32 in total

1.  CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.

Authors:  Christopher D Conrady; Min Zheng; Donald U Stone; Daniel J J Carr
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

2.  Towards an effective genital herpes vaccine: past lessons and future prospects.

Authors:  William P Halford
Journal:  Future Virol       Date:  2007-01-01       Impact factor: 1.831

3.  Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.

Authors:  Xiuli Zhang; Annie Issagholian; Eric A Berg; Jordan B Fishman; Anthony B Nesburn; Lbachir BenMohamed
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.

Authors:  Derek J Royer; Min Zheng; Christopher D Conrady; Daniel J J Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

5.  Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease.

Authors:  Patricia P Lopes; George Todorov; Thanh T Pham; Anthony B Nesburn; Elmostafa Bahraoui; Lbachir BenMohamed
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes.

Authors:  Brian S Sheridan; Thomas L Cherpes; Julie Urban; Pawel Kalinski; Robert L Hendricks
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.

Authors:  David M Koelle; Amalia Magaret; Christopher L McClurkan; Michael L Remington; Terri Warren; Florentina Teofilovici; Anna Wald
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

9.  Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

Authors:  Aziz Alami Chentoufi; Xavier Dervillez; Pierre-Alain Rubbo; Tiffany Kuo; Xiuli Zhang; Nicolas Nagot; Edouard Tuaillon; Philippe Van De Perre; Anthony B Nesburn; Lbachir Benmohamed
Journal:  Curr Trends Immunol       Date:  2012

10.  CD8 T cell control of HSV reactivation from latency is abrogated by viral inhibition of MHC class I.

Authors:  Mark T Orr; Meredith A Mathis; Michael Lagunoff; Jilian A Sacks; Christopher B Wilson
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.